MedTrace Logo

Evaluation of the User Experience of an Innovative Hospital Room Prototype Adapted to the Elderly

NCT05126212 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-11-18

No results posted yet for this study

Summary

Nowadays in France, the standards of hospital rooms are being questioned in view of the particularities of certain populations admitted to hospitals.

The " Groupement de Coopération Sanitaire des Hôpitaux Universitaires du Grand Ouest " (GCS HUGO) proposes to improve the quality of geriatric care through the modernisation of hospital rooms.

The GCS HUGO has launched a project to co-design a hospital room adapted to the elderly, called "Hospi'Senior", with the help of the "Dependency and Old Age" steering committee. This committee is made up of experts from HUGO and partner companies.

The Hospi'Senior room is composed of innovative technologies concerning bed equipment (e.g. bed canopy), autonomous (e.g. lifeline) and assisted mobility (e.g. rail lift system), lighting (e.g. light guide), communication (touch tablet) and social space (furniture).

The project consists in evaluating the user experience (UX) of :

* patients hospitalized in the Hospi'Senior room,
* informal caregivers of patients hospitalized in the Hospi'Senior room,
* caregivers who have worked in the Hospi'Senior room.

Conditions

  • User Experience

Interventions

OTHER

User experience

User experience is assessed by validated scale

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Cédric ANNWEILER, MD,PhD · Angers University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2023-12-01
Completion
2023-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05126212 on ClinicalTrials.gov